In RA pts initiating their first b/tsDMARD, Abs 1420 did not observe differences in 6- and 12-month effectiveness outcomes between ETN, ADA, and JAKi monotherapy. #ACR22 @RheumNow https://t.co/e8GA45Rrmd https://t.co/zooGxlTftO
Links:
Outcomes in Patients with Rheumatoid Arthritis Initiating Monotherapy with Etan…
http://ow.ly/jpMg50LzcVG
13-11-2022